Manufacturing and Production

Showing 15 posts of 5859 posts found.

shutterstock_273326141

AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn

November 13, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi

AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …
samsung

Samsung Biologics shares fall by 20% after Korean investigation

November 13, 2018 Manufacturing and Production Shares, accounting, pharma, smasung biologics, stockmarket

Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South …

Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma

November 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
dave_tudor

GSK veteran Dave Tudor joins MMIC in Scotland

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing

GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines

The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
helena-baker

Living with fibular hemimelia

November 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cambridge rare disease network, diagnosis, fibular hemimelia, rare disease, therapy

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease …
stock-exchange-911613_1920

Pharma stocks soar after US midterm elections

November 8, 2018 Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market

Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …
bicycle_therapeutics

Bicycle Therapeutics picks up former Pfizer head as new SVP of Pre-Clinical Development

November 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Cambridge based biotechnology firm Bicycle therapeutics, has announced former Pfizer head Dr Phil Jeffrey as the company’s new Senior …
uk

UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres

November 6, 2018 Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …
image_credit_-_rafael_matsunaga

Clearside Biomedical shares plummet by 56% after disappointing Phase 3 results

November 6, 2018 Manufacturing and Production

Shares in the US-based pharma firm Clearside Biomedical plummeted on Monday after the company announced disappointing phase III trial results …
450px-official_portrait_of_matt_hancock_crop_2

Health Secretary launches new prevention strategy for NHS

November 6, 2018 Manufacturing and Production Matt Hancock, NHS, health, prevention

British Health Secretary Matt Hancock has said that healthcare should focus on prevention, as he launched a long-term strategy intended …

AstraZeneca sells off three drugs in deal worth $350 million

November 6, 2018 Manufacturing and Production AstraZeneca, asthma, covis, deal, royalties

Anglo-Swedish multinational AstraZeneca has agreed to sell the rights to three asthma and rhinitis drugs in a deal worth $350 …
janssen_latest_logo_on_sign_closer

J&J buy global rights to Yuhan’s lazertinib in deal worth $1.2bn

November 6, 2018 Manufacturing and Production J&J, JJ, NSCLC, Yuhan, deal, lazertinib, south korea

Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan’s third-generation EGFR tyrosine kinase inhibitor (TKI) lazertinib in a deal …
The Gateway to Local Adoption Series

Latest content